Shelter Pharma Board Approves Conversion of 2,79,000 Warrants into Equity Shares

Shelter Pharma Limited has successfully completed the conversion of 2,79,000 warrants into equity shares, raising ₹88.40 lakh through the exercise of conversion rights by non-promoter warrant holders. The board of directors approved this conversion during their meeting held on March 07, 2026, as disclosed in the official regulatory filing to BSE Limited. Board Meeting Outcome and Regulatory Compliance The conversion was executed in accordance with Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The board meeting commenced at 12:15 PM and concluded at 12:45 PM, with the directors approving the allotment of 2,79,000 equity shares of face value ₹10.00 each upon warrant conversion. Parameter: Details Total Warrants Converted: 2,79,000 Exercise Price per Warrant: ₹31.69 Total Amount Raised: ₹88.40 lakh Face Value per Share: ₹10.00 Issue Price per Share: ₹42.25 Investor Participation Details Three non-promoter investors participated in the warrant conversion process with varying levels of participation. Rishabh Nayambhai Sharma converted 99,000 warrants out of his total holding of 5,40,000, having previously converted 2,01,000 warrants. Nayana Kamlesh Sheth fully converted her entire holding of 1,02,000 warrants, while Dipika Pankajbhai Patel converted 78,000 out of her 99,000 warrants. Investor: Warrants Converted Amount Paid (₹) Outstanding Warrants Rishabh Nayambhai Sharma: 99,000 31.37 lakh 2,40,000 Nayana Kamlesh Sheth: 1,02,000 32.32 lakh 0 Dipika Pankajbhai Patel: 78,000 24.72 lakh 21,000 Capital Structure Enhancement The warrant conversion has resulted in a substantial increase in the company's paid-up equity share capital. The capital base expanded from ₹16.33 crore consisting of 1.63 crore equity shares to ₹16.61 crore comprising 1.66 crore equity shares, each with a face value of ₹10.00. Metric: Before Conversion After Conversion Change Paid-up Capital: ₹16.33 crore ₹16.61 crore ₹0.28 crore Total Equity Shares: 1.63 crore 1.66 crore 2.79 lakh Outstanding Warrants: - - 2.61 lakh Background and Future Steps The original warrant allotment of 88.08 lakh warrants was approved by shareholders at an extraordinary general meeting held on July 23, 2025, with BSE providing in-principle approval on July 22, 2025. The warrants were issued at ₹42.25 each with warrant holders paying 25% upfront and the remaining 75% upon conversion. The newly allotted equity shares will rank pari-passu with existing equity shares in all respects, ensuring equal rights for all shareholders. The company will submit applications for listing and trading approval of the newly issued equity shares to the stock exchange in due course. The successful conversion demonstrates continued investor confidence in the company's growth prospects and provides additional capital for business operations. Shelter Pharma Limited has announced the launch of FitKick Pro powder, marking a significant expansion of its nutraceutical portfolio. The pre-workout supplement is available in three distinct flavors: American Licorice, Mixed Berries, and Orange Mango, targeting the rapidly growing domestic and international wellness market. Strategic Market Expansion The launch represents Shelter Pharma's strategic initiative to strengthen its presence in the nutraceutical and preventive healthcare segment. With six decades of experience in natural healing since its establishment in 1965, the company has built its reputation on tradition, integrity, and continuous progress. The expansion into pre-workout supplements demonstrates the company's commitment to combining traditional wisdom with modern, forward-looking approaches. Product Features and Benefits The FitKick Pro powder is formulated with potent ingredients designed to deliver maximum performance benefits without post-workout energy crashes. The product offers several key advantages for fitness enthusiasts: Benefit Description Explosive Strength Surge of energy and motivation for tough workouts Improved Endurance Increased stamina to train harder and longer Enhanced Focus Laser-like concentration for maximized training Muscle Pump Amplified blood flow and nutrient delivery Zero Sugar Delicious flavors without added sugar Product Portfolio Strategy The FitKick Pro launch aligns with Shelter Pharma's broader strategy to build a diverse portfolio of high-quality, accessible wellness products that cater to evolving consumer needs. The company focuses on delivering science-backed nutritional solutions while maintaining its core commitment to natural healing principles. Market Positioning Shelter Pharma positions itself as a trusted name in herbal remedies, combining extensive research and development with state-of-the-art technology. The company's aggressive, professional approach aims to improve lives with trusted, effective solutions worldwide while leading the future of natural healthcare. Growth Prospects The company believes the FitKick Pro launch will contribute positively to its growth prospects and reinforce its commitment to providing high-quality nutritional solutions. As Shelter Pharma deepens its presence in the nutraceutical sector, the company aims to deliver sustained growth, strengthen brand equity, and create long-term value for customers, partners, and investors. We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better. Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians. As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.